Experiment: 2JTY

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
2	2D 1H-13C HSQC	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
3	3D HNCO	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
4	3D HNCA	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
5	3D HNCACB	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
6	3D HN(CO)CA	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
7	3D 1H-15N NOESY	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
8	3D 1H-13C NOESY	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
9	3D 1H-15N TOCSY	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
10	3D HCCH-TOCSY	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
11	CBHD	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
12	3D 1H-13C NOESY aro	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298
13	2D 1H-13C HSQC aro	1.7 mM [U-98% 13C; U-98% 15N] FimA, 50 M H2O, 5 M D2O	95% H2O/5% D2O	18	7.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	900
2	Bruker	DRX	750

NMR Refinement
Method	Details	Software
torsion angle dynamics, molecular dynamics	torsion angle dynamics using DYANA and molecular dynamics using Opal	CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA		Guntert
2	refinement	OPAL

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.